Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 57

1.

Trends in Rates of Infections Requiring Hospitalization Among Adults With Versus Without Diabetes in the U.S., 2000-2015.

Harding JL, Benoit SR, Gregg EW, Pavkov ME, Perreault L.

Diabetes Care. 2019 Oct 15. pii: dc190653. doi: 10.2337/dc19-0653. [Epub ahead of print]

PMID:
31615853
2.

Trends in incidence of total or type 2 diabetes: systematic review.

Magliano DJ, Islam RM, Barr ELM, Gregg EW, Pavkov ME, Harding JL, Tabesh M, Koye DN, Shaw JE.

BMJ. 2019 Sep 11;366:l5003. doi: 10.1136/bmj.l5003.

3.

The relation between dialysis-requiring acute kidney injury and recovery from end-stage renal disease: a national study.

Chen Z, Lee BJ, McCulloch CE, Burrows NR, Heung M, Hsu RK, Pavkov ME, Powe NR, Saran R, Shahinian V, Hsu CY; Centers for Disease Control and Prevention Chronic Kidney Disease Surveillance Team.

BMC Nephrol. 2019 Sep 2;20(1):342. doi: 10.1186/s12882-019-1483-y.

4.

Estimating GFR in the Elderly-New Approaches to an Old Problem.

Pavkov ME, Nelson RG.

Kidney Int Rep. 2019 Apr 10;4(6):763-765. doi: 10.1016/j.ekir.2019.04.006. eCollection 2019 Jun. No abstract available.

5.

Trends of Nontraumatic Lower-Extremity Amputation in End-Stage Renal Disease and Diabetes: United States, 2000-2015.

Harding JL, Pavkov ME, Gregg EW, Burrows NR.

Diabetes Care. 2019 Aug;42(8):1430-1435. doi: 10.2337/dc19-0296. Epub 2019 May 29.

6.

A signature of circulating inflammatory proteins and development of end-stage renal disease in diabetes.

Niewczas MA, Pavkov ME, Skupien J, Smiles A, Md Dom ZI, Wilson JM, Park J, Nair V, Schlafly A, Saulnier PJ, Satake E, Simeone CA, Shah H, Qiu C, Looker HC, Fiorina P, Ware CF, Sun JK, Doria A, Kretzler M, Susztak K, Duffin KL, Nelson RG, Krolewski AS.

Nat Med. 2019 May;25(5):805-813. doi: 10.1038/s41591-019-0415-5. Epub 2019 Apr 22.

PMID:
31011203
7.

Poor accordance to a DASH dietary pattern is associated with higher risk of ESRD among adults with moderate chronic kidney disease and hypertension.

Banerjee T, Crews DC, Tuot DS, Pavkov ME, Burrows NR, Stack AG, Saran R, Bragg-Gresham J, Powe NR; Centers for Disease Control and Prevention Chronic Kidney Disease Surveillance Team.

Kidney Int. 2019 Jun;95(6):1433-1442. doi: 10.1016/j.kint.2018.12.027. Epub 2019 Mar 4.

PMID:
30975440
8.

Prevalence of Diabetic Retinopathy and Associated Mortality Among Diabetic Adults With and Without Chronic Kidney Disease.

Pavkov ME, Harding JL, Chou CF, Saaddine JB.

Am J Ophthalmol. 2019 Feb;198:200-208. doi: 10.1016/j.ajo.2018.10.019. Epub 2018 Oct 25.

PMID:
30691612
9.

Prevalence of Tuberculosis Disease Among Adult US-Bound Refugees with Chronic Kidney Disease.

Bardenheier BH, Pavkov ME, Winston CA, Klosovsky A, Yen C, Benoit S, Gravenstein S, Posey DL, Phares CR.

J Immigr Minor Health. 2019 Jan 5. doi: 10.1007/s10903-018-00852-8. [Epub ahead of print]

PMID:
30612283
10.

Trends in Incidence of ESKD in People With Type 1 and Type 2 Diabetes in Australia, 2002-2013.

Koye DN, Magliano DJ, Reid CM, Pavkov ME, Chadban SJ, McDonald SP, Polkinghorne KR, White S, Paul C, Shaw JE.

Am J Kidney Dis. 2019 Mar;73(3):300-308. doi: 10.1053/j.ajkd.2018.10.005. Epub 2018 Dec 19.

PMID:
30579709
11.

Association of Monoclonal Gammopathy with Progression to ESKD among US Veterans.

Burwick N, Adams SV, Todd-Stenberg JA, Burrows NR, Pavkov ME, O'Hare AM.

Clin J Am Soc Nephrol. 2018 Dec 7;13(12):1810-1815. doi: 10.2215/CJN.06210518. Epub 2018 Nov 15.

PMID:
30442867
12.

Modeling the impact of obesity on the lifetime risk of chronic kidney disease in the United States using updated estimates of GFR progression from the CRIC study.

Yarnoff BO, Hoerger TJ, Shrestha SS, Simpson SK, Burrows NR, Anderson AH, Xie D, Chen HY, Pavkov ME; CRIC Study Investigators.

PLoS One. 2018 Oct 19;13(10):e0205530. doi: 10.1371/journal.pone.0205530. eCollection 2018.

13.

Global trends in diabetes complications: a review of current evidence.

Harding JL, Pavkov ME, Magliano DJ, Shaw JE, Gregg EW.

Diabetologia. 2019 Jan;62(1):3-16. doi: 10.1007/s00125-018-4711-2. Epub 2018 Aug 31. Review.

14.

Trends in Albuminuria and GFR Among Adolescents in the United States, 1988-2014.

Saydah SH, Xie H, Imperatore G, Burrows NR, Pavkov ME.

Am J Kidney Dis. 2018 Nov;72(5):644-652. doi: 10.1053/j.ajkd.2018.04.021. Epub 2018 Jul 14.

PMID:
30017204
15.

The Global Epidemiology of Diabetes and Kidney Disease.

Koye DN, Magliano DJ, Nelson RG, Pavkov ME.

Adv Chronic Kidney Dis. 2018 Mar;25(2):121-132. doi: 10.1053/j.ackd.2017.10.011. Review.

PMID:
29580576
16.

Trends in Hospitalizations for Acute Kidney Injury - United States, 2000-2014.

Pavkov ME, Harding JL, Burrows NR.

MMWR Morb Mortal Wkly Rep. 2018 Mar 16;67(10):289-293. doi: 10.15585/mmwr.mm6710a2.

17.

Associations between persistent organic pollutants, type 2 diabetes, diabetic nephropathy and mortality.

Grice BA, Nelson RG, Williams DE, Knowler WC, Mason C, Hanson RL, Bullard KM, Pavkov ME.

Occup Environ Med. 2017 Jul;74(7):521-527. doi: 10.1136/oemed-2016-103948. Epub 2017 Apr 24.

18.

Colon Cancer Screening among Patients Receiving Dialysis in the United States: Are We Choosing Wisely?

Carlos CA, McCulloch CE, Hsu CY, Grimes B, Pavkov ME, Burrows NR, Shahinian VB, Saran R, Powe NR, Johansen KL; Centers for Disease Control and Prevention Chronic Kidney Disease Surveillance Team.

J Am Soc Nephrol. 2017 Aug;28(8):2521-2528. doi: 10.1681/ASN.2016091019. Epub 2017 Mar 23.

19.

The cost-effectiveness of using chronic kidney disease risk scores to screen for early-stage chronic kidney disease.

Yarnoff BO, Hoerger TJ, Simpson SK, Leib A, Burrows NR, Shrestha SS, Pavkov ME; Centers for Disease Control and Prevention CKD Initiative.

BMC Nephrol. 2017 Mar 13;18(1):85. doi: 10.1186/s12882-017-0497-6.

20.

Estimation of chronic kidney disease incidence from prevalence and mortality data in American Indians with type 2 diabetes.

Vijayakumar P, Hoyer A, Nelson RG, Brinks R, Pavkov ME.

PLoS One. 2017 Feb 6;12(2):e0171027. doi: 10.1371/journal.pone.0171027. eCollection 2017.

21.

Metabolically Healthy Obesity and Development of Chronic Kidney Disease.

Kahn HS, Pavkov ME.

Ann Intern Med. 2016 Nov 15;165(10):743. doi: 10.7326/L16-0407. No abstract available.

22.

Trends in Prevalence of Chronic Kidney Disease in the United States.

Murphy D, McCulloch CE, Lin F, Banerjee T, Bragg-Gresham JL, Eberhardt MS, Morgenstern H, Pavkov ME, Saran R, Powe NR, Hsu CY; Centers for Disease Control and Prevention Chronic Kidney Disease Surveillance Team.

Ann Intern Med. 2016 Oct 4;165(7):473-481. doi: 10.7326/M16-0273. Epub 2016 Aug 2.

23.

The Cost-Effectiveness of Anemia Treatment for Persons with Chronic Kidney Disease.

Yarnoff BO, Hoerger TJ, Simpson SA, Pavkov ME, Burrows NR, Shrestha SS, Williams DE, Zhuo X.

PLoS One. 2016 Jul 12;11(7):e0157323. doi: 10.1371/journal.pone.0157323. eCollection 2016.

24.

Acute Kidney Injury Recovery Pattern and Subsequent Risk of CKD: An Analysis of Veterans Health Administration Data.

Heung M, Steffick DE, Zivin K, Gillespie BW, Banerjee T, Hsu CY, Powe NR, Pavkov ME, Williams DE, Saran R, Shahinian VB; Centers for Disease Control and Prevention CKD Surveillance Team.

Am J Kidney Dis. 2016 May;67(5):742-52. doi: 10.1053/j.ajkd.2015.10.019. Epub 2015 Dec 12.

PMID:
26690912
25.

Exploring Potential Reasons for the Temporal Trend in Dialysis-Requiring AKI in the United States.

Hsu RK, McCulloch CE, Heung M, Saran R, Shahinian VB, Pavkov ME, Burrows NR, Powe NR, Hsu CY; Centers for Disease Control and Prevention Chronic Kidney Disease Surveillance Team.

Clin J Am Soc Nephrol. 2016 Jan 7;11(1):14-20. doi: 10.2215/CJN.04520415. Epub 2015 Dec 18.

26.

Tumor necrosis factor receptors 1 and 2 are associated with early glomerular lesions in type 2 diabetes.

Pavkov ME, Weil EJ, Fufaa GD, Nelson RG, Lemley KV, Knowler WC, Niewczas MA, Krolewski AS.

Kidney Int. 2016 Jan;89(1):226-34. doi: 10.1038/ki.2015.278. Epub 2016 Jan 4.

27.

In reply to 'the myth of the future burden of CKD in United States'.

Hoerger TJ, Ríos Burrows N, Pavkov ME.

Am J Kidney Dis. 2015 Jul;66(1):172. doi: 10.1053/j.ajkd.2015.05.003. No abstract available.

28.

Filtration markers as predictors of ESRD and mortality in Southwestern American Indians with type 2 diabetes.

Foster MC, Inker LA, Hsu CY, Eckfeldt JH, Levey AS, Pavkov ME, Myers BD, Bennett PH, Kimmel PL, Vasan RS, Coresh J, Nelson RG; CKD Biomarkers Consortium.

Am J Kidney Dis. 2015 Jul;66(1):75-83. doi: 10.1053/j.ajkd.2015.01.013. Epub 2015 Mar 12.

29.

The future burden of CKD in the United States: a simulation model for the CDC CKD Initiative.

Hoerger TJ, Simpson SA, Yarnoff BO, Pavkov ME, Ríos Burrows N, Saydah SH, Williams DE, Zhuo X.

Am J Kidney Dis. 2015 Mar;65(3):403-11. doi: 10.1053/j.ajkd.2014.09.023. Epub 2014 Nov 5.

PMID:
25468386
30.

Elevation of circulating TNF receptors 1 and 2 increases the risk of end-stage renal disease in American Indians with type 2 diabetes.

Pavkov ME, Nelson RG, Knowler WC, Cheng Y, Krolewski AS, Niewczas MA.

Kidney Int. 2015 Apr;87(4):812-9. doi: 10.1038/ki.2014.330. Epub 2014 Oct 1.

31.

Race and other risk factors for incident proteinuria in a national cohort of HIV-infected veterans.

Banerjee T, Scherzer R, Powe NR, Steffick D, Shahinian V, Saran R, Pavkov ME, Saydah S, Shlipak MG; Centers for Disease Control and Prevention Chronic Kidney Disease Surveillance Team.

J Acquir Immune Defic Syndr. 2014 Oct 1;67(2):145-52. doi: 10.1097/QAI.0000000000000285.

32.

Awareness of kidney disease among US adults: Findings from the 2011 behavioral risk factor surveillance system.

Li C, Wen XJ, Pavkov ME, Zhao G, Balluz LS, Ford ES, Williams D, Gotway CA.

Am J Nephrol. 2014;39(4):306-13. doi: 10.1159/000360184. Epub 2014 Apr 12.

33.

Improved early risk stratification with cystatin C-based estimated GFR.

Pavkov ME, Nelson RG.

Am J Kidney Dis. 2014 May;63(5):745-8. doi: 10.1053/j.ajkd.2014.02.006. Epub 2014 Mar 4. No abstract available.

34.

Comparison of serum cystatin C, serum creatinine, measured GFR, and estimated GFR to assess the risk of kidney failure in American Indians with diabetic nephropathy.

Pavkov ME, Knowler WC, Hanson RL, Williams DE, Lemley KV, Myers BD, Nelson RG.

Am J Kidney Dis. 2013 Jul;62(1):33-41. doi: 10.1053/j.ajkd.2012.11.044. Epub 2013 Jan 21.

35.

Albuminuria prevalence in first morning void compared with previous random urine from adults in the National Health and Nutrition Examination Survey, 2009-2010.

Saydah SH, Pavkov ME, Zhang C, Lacher DA, Eberhardt MS, Burrows NR, Narva AS, Eggers PW, Williams DE.

Clin Chem. 2013 Apr;59(4):675-83. doi: 10.1373/clinchem.2012.195644. Epub 2013 Jan 11.

36.

Cost-effectiveness of screening for microalbuminuria among African Americans.

Hoerger TJ, Wittenborn JS, Zhuo X, Pavkov ME, Burrows NR, Eggers P, Jordan R, Saydah S, Williams DE.

J Am Soc Nephrol. 2012 Dec;23(12):2035-41. doi: 10.1681/ASN.2012040347.

37.

Trajectories of kidney function decline in the 2 years before initiation of long-term dialysis.

O'Hare AM, Batten A, Burrows NR, Pavkov ME, Taylor L, Gupta I, Todd-Stenberg J, Maynard C, Rodriguez RA, Murtagh FE, Larson EB, Williams DE.

Am J Kidney Dis. 2012 Apr;59(4):513-22. doi: 10.1053/j.ajkd.2011.11.044. Epub 2012 Feb 4.

38.

Early renal function decline in type 2 diabetes.

Pavkov ME, Knowler WC, Lemley KV, Mason CC, Myers BD, Nelson RG.

Clin J Am Soc Nephrol. 2012 Jan;7(1):78-84. doi: 10.2215/CJN.07610711. Epub 2011 Nov 10.

39.

Intra-abdominal pressure can be estimated inexpensively by the sagittal abdominal diameter.

Kahn HS, Pavkov ME.

Am J Kidney Dis. 2011 Jun;57(6):959; author reply 959-60. doi: 10.1053/j.ajkd.2011.03.007. No abstract available.

PMID:
21601129
40.

Effect of intrauterine diabetes exposure on the incidence of end-stage renal disease in young adults with type 2 diabetes.

Pavkov ME, Hanson RL, Knowler WC, Sievers ML, Bennett PH, Nelson RG.

Diabetes Care. 2010 Nov;33(11):2396-8. doi: 10.2337/dc10-0811. Epub 2010 Aug 6.

41.

Prognostic implications of the urinary albumin to creatinine ratio in veterans of different ages with diabetes.

O'Hare AM, Hailpern SM, Pavkov ME, Rios-Burrows N, Gupta I, Maynard C, Todd-Stenberg J, Rodriguez RA, Hemmelgarn BR, Saran R, Williams DE.

Arch Intern Med. 2010 Jun 14;170(11):930-6. doi: 10.1001/archinternmed.2010.129. Erratum in: Arch Intern Med. 2010 Oct 11;170(18):1639.

PMID:
20548004
42.

Toward a more collaborative federal response to chronic kidney disease.

Narva AS, Briggs M, Jordan R, Pavkov ME, Burrows NR, Williams DE.

Adv Chronic Kidney Dis. 2010 May;17(3):282-8. doi: 10.1053/j.ackd.2010.03.006.

43.

Predictive value of albuminuria in American Indian youth with or without type 2 diabetes.

Kim NH, Pavkov ME, Knowler WC, Hanson RL, Weil EJ, Curtis JM, Bennett PH, Nelson RG.

Pediatrics. 2010 Apr;125(4):e844-51. doi: 10.1542/peds.2009-1230. Epub 2010 Mar 1.

44.

A health policy model of CKD: 1. Model construction, assumptions, and validation of health consequences.

Hoerger TJ, Wittenborn JS, Segel JE, Burrows NR, Imai K, Eggers P, Pavkov ME, Jordan R, Hailpern SM, Schoolwerth AC, Williams DE; Centers for Disease Control and Prevention CKD Initiative.

Am J Kidney Dis. 2010 Mar;55(3):452-62. doi: 10.1053/j.ajkd.2009.11.016. Epub 2010 Feb 8.

PMID:
20116911
45.

A health policy model of CKD: 2. The cost-effectiveness of microalbuminuria screening.

Hoerger TJ, Wittenborn JS, Segel JE, Burrows NR, Imai K, Eggers P, Pavkov ME, Jordan R, Hailpern SM, Schoolwerth AC, Williams DE; Centers for Disease Control and Prevention CKD Initiative.

Am J Kidney Dis. 2010 Mar;55(3):463-73. doi: 10.1053/j.ajkd.2009.11.017. Epub 2010 Feb 8.

PMID:
20116910
46.

The separate and joint effects of prolonged QT interval and heart rate on mortality.

Kim NH, Pavkov ME, Nelson RG, Hanson RL, Bennett PH, Curtis JM, Sievers ML, Knowler WC.

Atherosclerosis. 2010 Apr;209(2):539-44. doi: 10.1016/j.atherosclerosis.2009.09.026. Epub 2009 Oct 1.

PMID:
19878945
47.

Change in the distribution of albuminuria according to estimated glomerular filtration rate in Pima Indians with type 2 diabetes.

Pavkov ME, Mason CC, Bennett PH, Curtis JM, Knowler WC, Nelson RG.

Diabetes Care. 2009 Oct;32(10):1845-50. doi: 10.2337/dc08-2325. Epub 2009 Jul 10.

48.

Diabetic nephropathy in American Indians, with a special emphasis on the Pima Indians.

Pavkov ME, Knowler WC, Hanson RL, Nelson RG.

Curr Diab Rep. 2008 Dec;8(6):486-93. Review.

49.

Changing course of diabetic nephropathy in the Pima Indians.

Nelson RG, Pavkov ME, Hanson RL, Knowler WC.

Diabetes Res Clin Pract. 2008 Nov 13;82 Suppl 1:S10-4. doi: 10.1016/j.diabres.2008.09.014. Epub 2008 Oct 7. Review.

50.

Predictive power of sequential measures of albuminuria for progression to ESRD or death in Pima Indians with type 2 diabetes.

Pavkov ME, Knowler WC, Hanson RL, Bennett PH, Nelson RG.

Am J Kidney Dis. 2008 May;51(5):759-66. doi: 10.1053/j.ajkd.2008.01.011. Epub 2008 Mar 20.

Supplemental Content

Loading ...
Support Center